Compare Impel Pharmaceuticals vs Travanti Pharma
Customers evaluate the quality of Impel Pharmaceuticals's products using the following success metrics.
Overview
Impel Pharmaceuticals is 16 yrs old and is based in United States.
Impel Pharmaceuticals (NASDAQ: IMPL) operates as a biotechnology company devoted to creating therapies for central nervous system (CNS) diseases. The company's products are based on a nasal drug delivery platform, the precision olfactory delivery (POD) device, that administers drugs to the upper nasal cavity in a consistent and predictable manner. It was founded in 2008 and is based in Seattle, Washington.
Travanti Pharma is 27 yrs old and is based in United States.
Transdermal delivery of drugs and cosmetic agents utilizing active-patch technology. The company was acquired by Teikoku.
Demo Video
Leadership
Adrian Adams (Chief Executive Officer)
Carter Anderson (Founder)
Funding
Investors
Vivo Capital, venBIO
Prolog Ventures, Spring Bay Companies
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Impel Pharmaceuticals has not claimed their profile.
Work for Impel Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Impel Pharmaceuticals?
Claim your profile now.
Information not available because Travanti Pharma has not claimed their profile.
Work for Travanti Pharma? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Travanti Pharma?
Claim your profile now.